Selected research
Market Outlook & Growth Opportunities
Global Medical Devices Genotoxicity Testing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Medical Devices Genotoxicity Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Medical Devices Genotoxicity Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Medical Devices Genotoxicity Testing Service market include TÜV SÜD, NAMSA, Eurofins Scientific, SGS SA, Nelson Labs, CD Bioarticle, UL Solutions, Measurlabs and STC Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Medical Devices Genotoxicity Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Devices Genotoxicity Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Devices Genotoxicity Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Devices Genotoxicity Testing Service market.
Medical Devices Genotoxicity Testing Service Segment by Company
TÜV SÜD
NAMSA
Eurofins Scientific
SGS SA
Nelson Labs
CD Bioarticle
UL Solutions
Measurlabs
STC Group
STEMart
Porsolt
TheraIndx
GBA Group
Adita Biosys
Adgyl Lifesciences
Medical Devices Genotoxicity Testing Service Segment by Type
In Vitro Testing
In Vivo Testing
Medical Devices Genotoxicity Testing Service Segment by Application
Implantable Devices
Polymer Devices
Drug Coating/Combination Devices
Others
Medical Devices Genotoxicity Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Medical Devices Genotoxicity Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Medical Devices Genotoxicity Testing Service key companies, revenue, market share, and recent developments.
3. To split the Medical Devices Genotoxicity Testing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Medical Devices Genotoxicity Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medical Devices Genotoxicity Testing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Medical Devices Genotoxicity Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Devices Genotoxicity Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Devices Genotoxicity Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Devices Genotoxicity Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Devices Genotoxicity Testing Service industry.
Chapter 3: Detailed analysis of Medical Devices Genotoxicity Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Medical Devices Genotoxicity Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Medical Devices Genotoxicity Testing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Medical Devices Genotoxicity Testing Service Industry Trends
Table 2. Medical Devices Genotoxicity Testing Service Industry Drivers
Table 3. Medical Devices Genotoxicity Testing Service Industry Opportunities and Challenges
Table 4. Medical Devices Genotoxicity Testing Service Industry Restraints
Table 5. Global Medical Devices Genotoxicity Testing Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Medical Devices Genotoxicity Testing Service Revenue Share by Company (2021-2026)
Table 7. Global Medical Devices Genotoxicity Testing Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Medical Devices Genotoxicity Testing Service Key Company Manufacturing Base & Headquarters
Table 9. Global Medical Devices Genotoxicity Testing Service Company, Product Type & Application
Table 10. Global Medical Devices Genotoxicity Testing Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Medical Devices Genotoxicity Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of In Vitro Testing
Table 15. Significant Companies of In Vivo Testing
Table 16. Global Medical Devices Genotoxicity Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Medical Devices Genotoxicity Testing Service Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Medical Devices Genotoxicity Testing Service Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Type (2021-2026)
Table 20. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Implantable Devices
Table 22. Significant Companies of Polymer Devices
Table 23. Significant Companies of Drug Coating/Combination Devices
Table 24. Significant Companies of Others
Table 25. Global Medical Devices Genotoxicity Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Medical Devices Genotoxicity Testing Service Sales Value by Application (2021-2026) & (US$ Million)
Table 27. Global Medical Devices Genotoxicity Testing Service Sales Value by Application (2027-2032) & (US$ Million)
Table 28. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Application (2021-2026)
Table 29. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Application (2027-2032)
Table 30. Global Medical Devices Genotoxicity Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Medical Devices Genotoxicity Testing Service Sales Value by Region (2021-2026) & (US$ Million)
Table 32. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Region (2021-2026)
Table 33. Global Medical Devices Genotoxicity Testing Service Sales Value by Region (2027-2032) & (US$ Million)
Table 34. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Region (2027-2032)
Table 35. Global Medical Devices Genotoxicity Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 36. Global Medical Devices Genotoxicity Testing Service Sales Value by Country (2021-2026) & (US$ Million)
Table 37. Global Medical Devices Genotoxicity Testing Service Sales Value Market Share by Country (2021-2026)
Table 38. Global Medical Devices Genotoxicity Testing Service Sales Value by Country (2027-2032) & (US$ Million)
Table 39. Global Medical Devices Genotoxicity Testing Service Sales Value Market Share by Country (2027-2032)
Table 40. TÜV SÜD Company Information
Table 41. TÜV SÜD Business Overview
Table 42. TÜV SÜD Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 43. TÜV SÜD Medical Devices Genotoxicity Testing Service Product Portfolio
Table 44. TÜV SÜD Recent Development
Table 45. NAMSA Company Information
Table 46. NAMSA Business Overview
Table 47. NAMSA Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 48. NAMSA Medical Devices Genotoxicity Testing Service Product Portfolio
Table 49. NAMSA Recent Development
Table 50. Eurofins Scientific Company Information
Table 51. Eurofins Scientific Business Overview
Table 52. Eurofins Scientific Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Eurofins Scientific Medical Devices Genotoxicity Testing Service Product Portfolio
Table 54. Eurofins Scientific Recent Development
Table 55. SGS SA Company Information
Table 56. SGS SA Business Overview
Table 57. SGS SA Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 58. SGS SA Medical Devices Genotoxicity Testing Service Product Portfolio
Table 59. SGS SA Recent Development
Table 60. Nelson Labs Company Information
Table 61. Nelson Labs Business Overview
Table 62. Nelson Labs Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 63. Nelson Labs Medical Devices Genotoxicity Testing Service Product Portfolio
Table 64. Nelson Labs Recent Development
Table 65. CD Bioarticle Company Information
Table 66. CD Bioarticle Business Overview
Table 67. CD Bioarticle Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. CD Bioarticle Medical Devices Genotoxicity Testing Service Product Portfolio
Table 69. CD Bioarticle Recent Development
Table 70. UL Solutions Company Information
Table 71. UL Solutions Business Overview
Table 72. UL Solutions Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. UL Solutions Medical Devices Genotoxicity Testing Service Product Portfolio
Table 74. UL Solutions Recent Development
Table 75. Measurlabs Company Information
Table 76. Measurlabs Business Overview
Table 77. Measurlabs Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Measurlabs Medical Devices Genotoxicity Testing Service Product Portfolio
Table 79. Measurlabs Recent Development
Table 80. STC Group Company Information
Table 81. STC Group Business Overview
Table 82. STC Group Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. STC Group Medical Devices Genotoxicity Testing Service Product Portfolio
Table 84. STC Group Recent Development
Table 85. STEMart Company Information
Table 86. STEMart Business Overview
Table 87. STEMart Medical Devices Genotoxicity Testing Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. STEMart Medical Devices Genotoxicity Testing Service Product Portfolio
Table 89. STEMart Recent Development
Table 90. Porsolt Company Information
Table 91. Porsolt Business Overview
Table 92. Porsolt Medical Devices Genotoxicity Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 93. Porsolt Medical Devices Genotoxicity Testing Service Product Portfolio
Table 94. Porsolt Recent Development
Table 95. TheraIndx Company Information
Table 96. TheraIndx Business Overview
Table 97. TheraIndx Medical Devices Genotoxicity Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 98. TheraIndx Medical Devices Genotoxicity Testing Service Product Portfolio
Table 99. TheraIndx Recent Development
Table 100. GBA Group Company Information
Table 101. GBA Group Business Overview
Table 102. GBA Group Medical Devices Genotoxicity Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 103. GBA Group Medical Devices Genotoxicity Testing Service Product Portfolio
Table 104. GBA Group Recent Development
Table 105. Adita Biosys Company Information
Table 106. Adita Biosys Business Overview
Table 107. Adita Biosys Medical Devices Genotoxicity Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 108. Adita Biosys Medical Devices Genotoxicity Testing Service Product Portfolio
Table 109. Adita Biosys Recent Development
Table 110. Adgyl Lifesciences Company Information
Table 111. Adgyl Lifesciences Business Overview
Table 112. Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 113. Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Product Portfolio
Table 114. Adgyl Lifesciences Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Authors List of This Report
Table 117. Secondary Sources
Table 118. Primary Sources
List of Figures
Figure 1. Medical Devices Genotoxicity Testing Service Product Image
Figure 2. Global Medical Devices Genotoxicity Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Medical Devices Genotoxicity Testing Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global Medical Devices Genotoxicity Testing Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. In Vitro Testing Image
Figure 8. In Vivo Testing Image
Figure 9. Global Medical Devices Genotoxicity Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Medical Devices Genotoxicity Testing Service Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Type (2021-2032)
Figure 12. Implantable Devices Image
Figure 13. Polymer Devices Image
Figure 14. Drug Coating/Combination Devices Image
Figure 15. Others Image
Figure 16. Global Medical Devices Genotoxicity Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 17. Global Medical Devices Genotoxicity Testing Service Sales Value Share 2021 VS 2025 VS 2032
Figure 18. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Application (2021-2032)
Figure 19. Global Medical Devices Genotoxicity Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 20. Global Medical Devices Genotoxicity Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 21. North America Medical Devices Genotoxicity Testing Service Sales Value (2021-2032) & (US$ Million)
Figure 22. North America Medical Devices Genotoxicity Testing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 23. Europe Medical Devices Genotoxicity Testing Service Sales Value (2021-2032) & (US$ Million)
Figure 24. Europe Medical Devices Genotoxicity Testing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Asia-Pacific Medical Devices Genotoxicity Testing Service Sales Value (2021-2032) & (US$ Million)
Figure 26. Asia-Pacific Medical Devices Genotoxicity Testing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 27. South America Medical Devices Genotoxicity Testing Service Sales Value (2021-2032) & (US$ Million)
Figure 28. South America Medical Devices Genotoxicity Testing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 29. Middle East & Africa Medical Devices Genotoxicity Testing Service Sales Value (2021-2032) & (US$ Million)
Figure 30. Middle East & Africa Medical Devices Genotoxicity Testing Service Sales Value Share by Country (%), 2025 VS 2032
Figure 31. USA Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 32. USA Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 33. USA Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 34. Canada Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 35. Canada Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 36. Canada Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 37. Mexico Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. Mexico Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. Mexico Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Germany Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Germany Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Germany Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. France Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. France Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. France Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. U.K. Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. U.K. Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. U.K. Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. Italy Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. Italy Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. Italy Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. Spain Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. Spain Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. Spain Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Russia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Russia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Russia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Netherlands Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Netherlands Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Netherlands Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Nordic Countries Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Nordic Countries Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. China Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. China Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. China Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Japan Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Japan Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Japan Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. South Korea Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. South Korea Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. South Korea Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. India Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. India Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. India Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. Australia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. Australia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. Australia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. Southeast Asia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. Southeast Asia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Brazil Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Brazil Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Brazil Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Argentina Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Argentina Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Argentina Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Chile Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Chile Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Chile Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Colombia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Colombia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Colombia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Peru Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Peru Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Peru Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Saudi Arabia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Saudi Arabia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Israel Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Israel Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Israel Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. UAE Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. UAE Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. UAE Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Turkey Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Turkey Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Turkey Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Iran Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Iran Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Iran Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Egypt Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Egypt Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Egypt Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Years Considered
Figure 116. Research Process
Figure 117. Key Executives Interviewed
Scope & coverage.
Types
- In Vitro Testing
- In Vivo Testing
Applications
- Implantable Devices
- Polymer Devices
- Drug Coating/Combination Devices
- Others
Companies covered
- TÜV SÜD
- NAMSA
- Eurofins Scientific
- SGS SA
- Nelson Labs
- CD Bioarticle
- UL Solutions
- Measurlabs
- STC Group
- STEMart
- Porsolt
- TheraIndx
- GBA Group
- Adita Biosys
- Adgyl Lifesciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Devices Genotoxicity Testing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Devices Genotoxicity Testing Service Market Dynamics
- 2.1 Medical Devices Genotoxicity Testing Service Industry Trends
- 2.2 Medical Devices Genotoxicity Testing Service Industry Drivers
- 2.3 Medical Devices Genotoxicity Testing Service Industry Opportunities and Challenges
- 2.4 Medical Devices Genotoxicity Testing Service Industry Restraints
3 Medical Devices Genotoxicity Testing Service Market by Company
- 3.1 Global Medical Devices Genotoxicity Testing Service Company Revenue Ranking in 2025
- 3.2 Global Medical Devices Genotoxicity Testing Service Revenue by Company (2021-2026)
- 3.3 Global Medical Devices Genotoxicity Testing Service Company Ranking (2024-2026)
- 3.4 Global Medical Devices Genotoxicity Testing Service Company Manufacturing Base and Headquarters
- 3.5 Global Medical Devices Genotoxicity Testing Service Company Product Type and Application
- 3.6 Global Medical Devices Genotoxicity Testing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Medical Devices Genotoxicity Testing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Medical Devices Genotoxicity Testing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Medical Devices Genotoxicity Testing Service Market by Type
- 4.1 Medical Devices Genotoxicity Testing Service Type Introduction
- 4.1.1 In Vitro Testing
- 4.1.2 In Vivo Testing
- 4.2 Global Medical Devices Genotoxicity Testing Service Sales Value by Type
- 4.2.1 Global Medical Devices Genotoxicity Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Devices Genotoxicity Testing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Medical Devices Genotoxicity Testing Service Sales Value Share by Type (2021-2032)
5 Medical Devices Genotoxicity Testing Service Market by Application
- 5.1 Medical Devices Genotoxicity Testing Service Application Introduction
- 5.1.1 Implantable Devices
- 5.1.2 Polymer Devices
- 5.1.3 Drug Coating/Combination Devices
- 5.1.4 Others
- 5.2 Global Medical Devices Genotoxicity Testing Service Sales Value by Application
- 5.2.1 Global Medical Devices Genotoxicity Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Devices Genotoxicity Testing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Medical Devices Genotoxicity Testing Service Sales Value Share by Application (2021-2032)
6 Medical Devices Genotoxicity Testing Service Regional Value Analysis
- 6.1 Global Medical Devices Genotoxicity Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Devices Genotoxicity Testing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Medical Devices Genotoxicity Testing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Medical Devices Genotoxicity Testing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Devices Genotoxicity Testing Service Sales Value (2021-2032)
- 6.3.2 North America Medical Devices Genotoxicity Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Medical Devices Genotoxicity Testing Service Sales Value (2021-2032)
- 6.4.2 Europe Medical Devices Genotoxicity Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Medical Devices Genotoxicity Testing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Medical Devices Genotoxicity Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Medical Devices Genotoxicity Testing Service Sales Value (2021-2032)
- 6.6.2 South America Medical Devices Genotoxicity Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Medical Devices Genotoxicity Testing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Medical Devices Genotoxicity Testing Service Sales Value Share by Country, 2025 VS 2032
7 Medical Devices Genotoxicity Testing Service Country-level Value Analysis
- 7.1 Global Medical Devices Genotoxicity Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Medical Devices Genotoxicity Testing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Medical Devices Genotoxicity Testing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Medical Devices Genotoxicity Testing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Medical Devices Genotoxicity Testing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Medical Devices Genotoxicity Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Medical Devices Genotoxicity Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 TÜV SÜD
- 8.1.1 TÜV SÜD Company Information
- 8.1.2 TÜV SÜD Business Overview
- 8.1.3 TÜV SÜD Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 TÜV SÜD Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.1.5 TÜV SÜD Recent Developments
- 8.2 NAMSA
- 8.2.1 NAMSA Company Information
- 8.2.2 NAMSA Business Overview
- 8.2.3 NAMSA Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 NAMSA Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.2.5 NAMSA Recent Developments
- 8.3 Eurofins Scientific
- 8.3.1 Eurofins Scientific Company Information
- 8.3.2 Eurofins Scientific Business Overview
- 8.3.3 Eurofins Scientific Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Eurofins Scientific Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.3.5 Eurofins Scientific Recent Developments
- 8.4 SGS SA
- 8.4.1 SGS SA Company Information
- 8.4.2 SGS SA Business Overview
- 8.4.3 SGS SA Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 SGS SA Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.4.5 SGS SA Recent Developments
- 8.5 Nelson Labs
- 8.5.1 Nelson Labs Company Information
- 8.5.2 Nelson Labs Business Overview
- 8.5.3 Nelson Labs Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Nelson Labs Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.5.5 Nelson Labs Recent Developments
- 8.6 CD Bioarticle
- 8.6.1 CD Bioarticle Company Information
- 8.6.2 CD Bioarticle Business Overview
- 8.6.3 CD Bioarticle Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 CD Bioarticle Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.6.5 CD Bioarticle Recent Developments
- 8.7 UL Solutions
- 8.7.1 UL Solutions Company Information
- 8.7.2 UL Solutions Business Overview
- 8.7.3 UL Solutions Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 UL Solutions Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.7.5 UL Solutions Recent Developments
- 8.8 Measurlabs
- 8.8.1 Measurlabs Company Information
- 8.8.2 Measurlabs Business Overview
- 8.8.3 Measurlabs Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Measurlabs Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.8.5 Measurlabs Recent Developments
- 8.9 STC Group
- 8.9.1 STC Group Company Information
- 8.9.2 STC Group Business Overview
- 8.9.3 STC Group Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 STC Group Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.9.5 STC Group Recent Developments
- 8.10 STEMart
- 8.10.1 STEMart Company Information
- 8.10.2 STEMart Business Overview
- 8.10.3 STEMart Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 STEMart Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.10.5 STEMart Recent Developments
- 8.11 Porsolt
- 8.11.1 Porsolt Company Information
- 8.11.2 Porsolt Business Overview
- 8.11.3 Porsolt Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Porsolt Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.11.5 Porsolt Recent Developments
- 8.12 TheraIndx
- 8.12.1 TheraIndx Company Information
- 8.12.2 TheraIndx Business Overview
- 8.12.3 TheraIndx Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 TheraIndx Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.12.5 TheraIndx Recent Developments
- 8.13 GBA Group
- 8.13.1 GBA Group Company Information
- 8.13.2 GBA Group Business Overview
- 8.13.3 GBA Group Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 GBA Group Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.13.5 GBA Group Recent Developments
- 8.14 Adita Biosys
- 8.14.1 Adita Biosys Company Information
- 8.14.2 Adita Biosys Business Overview
- 8.14.3 Adita Biosys Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Adita Biosys Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.14.5 Adita Biosys Recent Developments
- 8.15 Adgyl Lifesciences
- 8.15.1 Adgyl Lifesciences Company Information
- 8.15.2 Adgyl Lifesciences Business Overview
- 8.15.3 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Product Portfolio
- 8.15.5 Adgyl Lifesciences Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst